✦ LIBER ✦

Efficacy and safety of efalizumab in patients with chronic moderate to severe plaque psoriasis: Results from a postapproval phase IIIb/IV study (control II)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of efalizumab in the treatment

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Maintenance of efficacy and safety with

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Safety of efalizumab in adults with chro

✍ Kim A. Papp; Reni Bressinck; Scott Fretzin; Bernard Goffe; Steven Kempers; Kenne 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

Control of Moderate-to-Severe Plaque Pso

✍ Fernando M. Stengel; Valeria Petri; Gladys A.M. Campbell; Gladys Leon Dorantes; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Adalimumab in Japanese patients with mod

✍ Akihiko ASAHINA; Hidemi NAKAGAWA; Takafumi ETOH; Mamitaro OHTSUKI; THE ADALIMUMA 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 490 KB

Efficacy and Safety of Efalizumab in Pat

✍ Torello Lotti; Sergio Chimenti; Andreas Katsambas; Jean-Paul Ortonne; Louis Dube 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 267 KB